The Landmark Series: Neuroendocrine Tumor Liver Metastases

Speaking of SurgOnc

English - October 13, 2020 05:00 - 11 minutes - 13.7 MB - ★★★★★ - 6 ratings
Natural Sciences Science education globalcancersurgery research surgicaloncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies

Next Episode: The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cance

Rick Greene, MD, and Alexandra Gangi, MD and James Howe, MD, discuss current data regarding management of neuroendocrine liver metastases and future areas for study. Dr. Gangi and Dr. Howe are authors of “The Landmark Series: Neuroendocrine Tumor Liver Metastases.”

Dr. Gangi is Assistant Professor of Surgery in the Department of Surgical Oncology and the Director of the Gastrointestinal Tumor Program at Cedars-Sinai, Los Angeles, CA. Dr. James Howe is Professor of Surgery and Division Head of Surgical Oncology and Endocrine Surgery, University of Iowa Hospitals & Clinics, Iowa City, IA. Dr. Howe is also President of the North American Neuroendocrine Tumor Society and President of the Society of Surgical Oncology.